Bevacizumab Light chain

Bevacizumab Light chain – Cancer Peptides Light chain of the bevacizumab monoclonal antibody, sold as the antitumour therapeutic Avastin. It prevents vascular endothelial growth factor (VEGF) from binding to VEGF receptors 1 and 2 thus inhibiting angiogenesis in tumours. Technical specification Sequence : H-STAYLQMNSLR-OH MW : 1.282.6 g/mol Purity : > 95% Counter-Ion : […]

Technical Specifications

Sequence:	`H-STAYLQMNSLR-OH`
Purity:	> 95% (by HPLC)
Counter-Ion:	TFA Salts
Delivery Format:	Lyophilized

Product Description & Background

Bevacizumab Light chain – Cancer Peptides

Light chain of the bevacizumab monoclonal antibody, sold as the antitumour therapeutic Avastin. It prevents vascular endothelial growth factor (VEGF) from binding to VEGF receptors 1 and 2 thus inhibiting angiogenesis in tumours.

Technical specification

	Sequence :	H-STAYLQMNSLR-OH
	MW :	1.282.6 g/mol
	Purity :	> 95%
	Counter-Ion :	TFA Salts
	Delivery format :	Lyophilized

Price

Product	Size	Price €	Price $
CRB1001000-0.5 mg	0.5 mg	141€	170$
CRB1001000-1 mg	1 mg	193€	232$